000 | 02000 a2200625 4500 | ||
---|---|---|---|
005 | 20250518085214.0 | ||
264 | 0 | _c20200413 | |
008 | 202004s 0 0 eng d | ||
022 | _a1476-4687 | ||
024 | 7 |
_a10.1038/s41586-020-2015-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMoral, John Alec | |
245 | 0 | 0 |
_aILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity. _h[electronic resource] |
260 |
_bNature _c03 2020 |
||
300 |
_a130-135 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarcinoma, Pancreatic Ductal _xdrug therapy |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunity, Innate _ximmunology |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aInterleukin-33 _ximmunology |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 |
_aLymphocytes _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
700 | 1 | _aLeung, Joanne | |
700 | 1 | _aRojas, Luis A | |
700 | 1 | _aRuan, Jennifer | |
700 | 1 | _aZhao, Julia | |
700 | 1 | _aSethna, Zachary | |
700 | 1 | _aRamnarain, Anita | |
700 | 1 | _aGasmi, Billel | |
700 | 1 | _aGururajan, Murali | |
700 | 1 | _aRedmond, David | |
700 | 1 | _aAskan, Gokce | |
700 | 1 | _aBhanot, Umesh | |
700 | 1 | _aElyada, Ela | |
700 | 1 | _aPark, Youngkyu | |
700 | 1 | _aTuveson, David A | |
700 | 1 | _aGönen, Mithat | |
700 | 1 | _aLeach, Steven D | |
700 | 1 | _aWolchok, Jedd D | |
700 | 1 | _aDeMatteo, Ronald P | |
700 | 1 | _aMerghoub, Taha | |
700 | 1 | _aBalachandran, Vinod P | |
773 | 0 |
_tNature _gvol. 579 _gno. 7797 _gp. 130-135 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41586-020-2015-4 _zAvailable from publisher's website |
999 |
_c30652419 _d30652419 |